Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -114.94
- Piotroski Score 1.00
- Grade Hold
- Symbol (HEPA)
- Company Hepion Pharmaceuticals, Inc.
- Price $0.68
- Changes Percentage (-1.38%)
- Change -$0.01
- Day Low $0.66
- Day High $0.71
- Year High $4.47
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/26/2025
- Fiscal Year End N/A
- Average Stock Price Target $70.00
- High Stock Price Target $70.00
- Low Stock Price Target $70.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$9.40
- Trailing P/E Ratio -0.12
- Forward P/E Ratio -0.12
- P/E Growth -0.12
- Net Income $-48,926,042
Income Statement
Quarterly
Annual
Latest News of HEPA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Former Giants star Sterling Shepard reveals details on team's culture amid fallout from Daniel Jones' exit
Daniel Jones was released by the New York Giants after six seasons. The decision was described as mutual, with mixed reactions. Former player Sterling Shepard hinted at culture issues within the team....
By Fox News | 22 hours ago -
Blue Origin's New Shepard rocket to take six people to space,...
Blue Origin's New Shepard rocket is set to launch six individuals to space, including science host Emily Calandrelli, philanthropists, and an online prize winner. Calandrelli, known as "Space Gal," wi...
By New York Post | 5 days ago -
Shepard Fairey On The Power Of Art To Bring Out The Best Of Who We Are
Shepard Fairey is a renowned American artist blending street art with social messages. His iconic works critique consumerism, environmental issues, and social justice. Fairey's participation in the ex...
By Forbes | 2 weeks ago
